Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 68071-3567

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 68071-3567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)

Image (5cbe5633 F7a5 4357 Bb0d Ee421bd71c50 01)
Chemical structure diagram of cyclobenzaprine hydrochloride, showing the molecular arrangement including aromatic rings and amine groups associated with the compound.*
FDA Label Image

Pdp (68071 3567 3)

Pdp (68071 3567 3)
Label for Cyclobenzaprine Hydrochloride 5 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 30 tablets, round biconvex shape, debossed with 'U' and '1'. Includes dosage form, strength, manufacturer, storage instructions, and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.